Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Financing Small and Medium sized Companies on Top of Europe

29.04.2008
Biotech and Life sciences in the Baltic Sea Region needs collaboration between investors to overcome the lack of risk willing financing in the early SME development phases.

The lack of financing dramatically lowers the number of spin-outs from Universities and research institutions which passes the initial phase, where they are financed by public pre-seed financing.

Therefore Bioforum Oulu, Finland, is taking the lead in creating a "Top of Europe" financing network to assist closing the financial gap, which is a barrier for the exploitation of academic research in SME´s throughout the region. The Top of Europe financing network will be the theme for a workshop to be held 9th of June in Göteborg, where experts within financing of life sciences and biotech will discuss how to proceed in order to create a successful collaboration.

Program Director Tuula Palmén, Bioforum Oulu, says "We hope to promote the establishment of the Top of Europe financing network through dialogue with key stakeholders like private investors, SME´s, national and regional innovation and research agencies plus decision- and opinion makers. In order to strengthen competitiveness of the Baltic Sea Region we need to focus on the development of research based SME´s - otherwise we will loose ground to low costs countries".

The workshop in Göteborg is part of an EU co-funded project (FP 7) "Bridge-BSR" with 7 partners in addition to Bioforum Oulu: BioCan Valley, Estonian Biotech Association, IPPT-PAN, Latvian Association of Biotechnology, Medicon Valley Alliance, ScanBalt and Steinbeis Team North East. Bridge-BSR aims to bridge academic research and SME´s within life sciences and biotechnology in te Baltic Sea Region - ScanBalt BioRegion.

For further information please contact Tuula Palmén at tuula.palmen@bioforumoulu.org, Tel: +358 50 4617290, www.businessoulu.com

About Bioforum Oulu: Bioforum Oulu gathers together biotech companies, universities and R&D organisations in the Oulu region, Finland, and stimulates their co-operation. Bioforum Oulu works closely with other players in the region and also carries out spearhead projects named in the Oulu Growth Agreement. The intent is to develop new products and services that enhance people's health and well-being and to create new business in the field.

About ScanBalt BioRegion: ScanBalt BioRegion is composed of public and private Life Science and biotechnology actors in the Nordic countries, Balticum, Poland, Northern part of Germany and North western Russia. The ScanBalt BioRegion has 11 countries and 85 million people, more than 60 universities and 2149 life science/biotech companies including 671 research based biotech SME's.

Peter Frank | idw
Further information:
http://www.scanbalt.org

More articles from Business and Finance:

nachricht Microtechnology industry is hiring – positive developments of past years continue
09.04.2018 | IVAM Fachverband für Mikrotechnik

nachricht RWI/ISL-Container Throughput Index with minor decline on a high overall level
20.03.2018 | RWI – Leibniz-Institut für Wirtschaftsforschung

All articles from Business and Finance >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: A step towards controlling spin-dependent petahertz electronics by material defects

The operational speed of semiconductors in various electronic and optoelectronic devices is limited to several gigahertz (a billion oscillations per second). This constrains the upper limit of the operational speed of computing. Now researchers from the Max Planck Institute for the Structure and Dynamics of Matter in Hamburg, Germany, and the Indian Institute of Technology in Bombay have explained how these processes can be sped up through the use of light waves and defected solid materials.

Light waves perform several hundred trillion oscillations per second. Hence, it is natural to envision employing light oscillations to drive the electronic...

Im Focus: Freiburg researcher investigate the origins of surface texture

Most natural and artificial surfaces are rough: metals and even glasses that appear smooth to the naked eye can look like jagged mountain ranges under the microscope. There is currently no uniform theory about the origin of this roughness despite it being observed on all scales, from the atomic to the tectonic. Scientists suspect that the rough surface is formed by irreversible plastic deformation that occurs in many processes of mechanical machining of components such as milling.

Prof. Dr. Lars Pastewka from the Simulation group at the Department of Microsystems Engineering at the University of Freiburg and his team have simulated such...

Im Focus: Skyrmions like it hot: Spin structures are controllable even at high temperatures

Investigation of the temperature dependence of the skyrmion Hall effect reveals further insights into possible new data storage devices

The joint research project of Johannes Gutenberg University Mainz (JGU) and the Massachusetts Institute of Technology (MIT) that had previously demonstrated...

Im Focus: Making the internet more energy efficient through systemic optimization

Researchers at Chalmers University of Technology, Sweden, recently completed a 5-year research project looking at how to make fibre optic communications systems more energy efficient. Among their proposals are smart, error-correcting data chip circuits, which they refined to be 10 times less energy consumptive. The project has yielded several scientific articles, in publications including Nature Communications.

Streaming films and music, scrolling through social media, and using cloud-based storage services are everyday activities now.

Im Focus: New synthesis methods enhance 3D chemical space for drug discovery

After helping develop a new approach for organic synthesis -- carbon-hydrogen functionalization -- scientists at Emory University are now showing how this approach may apply to drug discovery. Nature Catalysis published their most recent work -- a streamlined process for making a three-dimensional scaffold of keen interest to the pharmaceutical industry.

"Our tools open up whole new chemical space for potential drug targets," says Huw Davies, Emory professor of organic chemistry and senior author of the paper.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

70th Lindau Nobel Laureate Meeting: Around 70 Laureates set to meet with young scientists from approx. 100 countries

12.02.2020 | Event News

11th Advanced Battery Power Conference, March 24-25, 2020 in Münster/Germany

16.01.2020 | Event News

Laser Colloquium Hydrogen LKH2: fast and reliable fuel cell manufacturing

15.01.2020 | Event News

 
Latest News

Active droplets

21.02.2020 | Medical Engineering

Finding new clues to brain cancer treatment

21.02.2020 | Health and Medicine

Beyond the brim, Sombrero Galaxy's halo suggests turbulent past

21.02.2020 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>